Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/82205
Type: Artigo
Title: Morphological characterization of a human glioma cell l ine
Author: Machado, C.M.L.
Genari, S.C.
Verinaud, L.
Vassallo, J.
Tamashiro, W.M.S.C.
Goncalves, E.M.
Schenka, A.
Abstract: A human malignant continuous cell line, named NG97, was recently established in our laboratory. This cell line has been serially subcultured over 100 times in standard culture media presenting no sign of cell senescence. The NG97 cell line has a doubling time of about 24 h. Immunocytochemical analysis of glial markers demonstrated that cells are positive for glial fibrillary acidic protein (GFAP) and S-100 protein, and negative for vimentin. Under phase-contrast microscope, cultures of NG97 showed cells with variable morphological features, such as small rounded cells, fusiform cells (fibroblastic-like cells), and dendritic-like cells. However, at confluence just small rounded and fusiform cells can be observed. At scanning electron microscopy (SEM) small rounded cells showed heterogeneous microextentions, including blebs and filopodia. Dendritic-like cells were flat and presented extensive prolongations, making several contacts with small rounded cells, while fusiform cells presented their surfaces dominated by microvilli. We believe that the knowledge about NG97 cell line may be useful for a deeper understanding of biological and immunological characteristics of gliomas
Subject: Proteína glial fibrilar ácida
Country: Reino Unido
Editor: Springer Nature
Citation: Cancer Cell International. Biomed Central Ltd, v. 5, 2005.
Rights: fechado
Identifier DOI: 10.1186/1475-2867-5-13
Address: https://cancerci.biomedcentral.com/articles/10.1186/1475-2867-5-13
Date Issue: 2005
Appears in Collections:IB - Artigos e Outros Documentos
FCM - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000208404900013.pdf718.39 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.